90078741
Jul 28, 2020
Implants comprising biological xenograft tissue, namely, natural and biologic valves for use in the repair of cardiac defects; Implants comprising biological xenograft tissue, namely, natural and biologic valves for vascular implantation; Implants comprising living tissue, namely, natural and biologic valves for internal vascular patient use; Implants comprising biological xenograft tissue, namely, natural and biologic valves for use in the repair of cardiac defects, sold as an integral component of a transcatheter aortic valve replacement (TAVR) system
PharmaceuticalsMedical devices, namely, transcatheter heart valve and heart valve delivery catheter, pericardial transcatheter aortic valve replacement apparatus, and structural parts therefor; aortic valve prostheses and structural parts therefor; artificial heart valves and structural parts therefor; artificial cardiac valves for vascular implantation, and parts and fittings therefor; heart prosthesis and bioprosthesis for the cardiovascular system; stents, and parts and fittings therefor; artificial stents, and parts and fittings therefor; cardiac stents, and parts and fittings therefor; cardiac valve replacement apparatus, and parts and fittings therefor; aortic valve replacement stents, and parts and fittings therefor
Medical Apparatus